Antibodies

View as table Download

Rabbit Polyclonal Anti-SARS Spike Antibody

Reactivities Yeast
Immunogen SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids at the amino-terminus of. The sARS Spike glycoprotein.

Rabbit Polyclonal Anti-SARS Spike Antibody

Reactivities Virus
Immunogen SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids near the center of. The sARS Spike glycoprotein.

Rabbit Polyclonal Anti-SARS Spike Antibody

Reactivities Virus
Immunogen SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids near the center of. The sARS Spike glycoprotein.

Rabbit Polyclonal Anti-SARS Spike Antibody

Reactivities Virus
Immunogen SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids near the center of. The sARS Spike glycoprotein.

Rabbit Polyclonal Anti-SARS Spike Antibody

Reactivities Virus
Immunogen SARS Spike antibody was raised against a synthetic peptide corresponding to amino acids at the carboxy terminus of the SARS Spike glycoprotein.

Mouse anti Hepatitis B virus surface Ag Monoclonal Antibody

Reactivities Human

Mouse anti HBsAg Monoclonal Antibody

Reactivities Human

Mouse anti HBsAg Monoclonal Antibody

Reactivities Human

Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)

Applications ELISA, IF
Conjugation Unconjugated

Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)

Applications ELISA, IF
Conjugation Unconjugated
Modifications This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)

Applications ELISA, IF
Conjugation Unconjugated
Modifications This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)

Applications ELISA, IF
Conjugation Unconjugated
Modifications This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)

Applications ELISA, IF
Conjugation Unconjugated
Modifications This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#14)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#14)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#14)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#14)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#14)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#16)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#16)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#16)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#16)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#16)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#42)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#42)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#42)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#42)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#42)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#45)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#45)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#45)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#45)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

Recombinant Anti-Spike protein (RBD) (Clone Sb#45)

Applications ELISA, Inhib
Conjugation Unconjugated
Modifications This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

SARS-CoV/SARS-CoV-2 Variant (Beta, Delta, Omicron (BA.5)) Spike Trimer Antibody [P1A7]

Applications ELISA
Reactivities Virus
Conjugation Unconjugated